New Treatment for Opioid-Induced Constipation

Thumbnail
Links to Files
https://ezproxy.stevenson.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=rzh&AN=107811913&site=eds-live&scope=site
Permanent Link
http://dx.doi.org/10.1097/01.NAJ.0000459622.00045.fd
http://hdl.handle.net/11603/5655
Collections
Metadata
Show full item record
Author/Creator
Date
2015-01
Type of Work
1 page
Text
journal articles
Department
Sandra R. Berman School of Nursing and Health Professions
Program
Nursing
Citation of Original Publication
Aschenbrenner, D. S. (2015). New treatment for opioid-induced constipation. AJN American Journal of Nursing, 115(1), 23. doi:10.1097/01.NAJ.0000459622.00045.fd
Abstract
The opioid antagonist naloxegol (Movantik) is now approved to treat opioid-induced constipation in adults with chronic noncancer pain. The most common adverse effects are abdominal pain, diarrhea, nausea, flatulence, vomiting, and headache.